Creso Pharma Limited (ASX:CPH)

Dr Miri Halperin Wernli
Group CEO
Market Cap (AUD): 126.33M
Sector: Health Care
Last Trade (AUD): 0.11 +0 (+0%)
Tab Bar

1. About

Creso Pharma Limited (ASX:CPH) was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver better lives to people and animals.

Creso Pharma develops cannabis and hemp derived therapeutic, nutraceutical, and life style products with wide patient and consumer reach for human and animal health.

Creso Pharma uses GMP (Good Manufacturing Practice) standards for its products as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk